Position in ZTS
as of Mar 31, 2026
· filed Apr 20, 2026
Position Value
$96,389,852
-$108,900,450 QoQ
Shares Held
815,412
-50.0% QoQ
Ownership
0.195%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Assenagon Asset Management S.A. holds $291,766,020 across 19 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (33.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
815,412 | $96,389,852 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,339,702 | $40,351,824 | |
| 3 | AMRX |
Amneal Pharmaceuticals, Inc.
|
3,067,361 | $38,127,297 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
47,183 | $27,978,575 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
530,618 | $27,427,644 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
91,478 | $12,051,311 | |
| 7 | VTRS |
Viatris Inc
|
783,134 | $10,580,140 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
312,598 | $10,337,615 |
All Filings in ZTS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $96,389,852 | 815,412 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $205,290,302 | 1,631,619 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $101,866,081 | 696,187 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $9,028,881 | 57,896 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $23,751,256 | 144,253 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $144,917,110 | 889,444 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $43,787,197 | 224,113 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $97,970,070 | 565,125 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $60,538,938 | 357,774 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $33,893,955 | 171,728 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $36,506,223 | 209,830 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $14,969,354 | 86,925 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $23,923,752 | 143,738 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $131,392,186 | 896,569 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $18,349,552 | 123,741 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $2,975,759 | 17,312 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $2,895,233 | 15,352 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $3,473,523 | 14,234 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $2,542,457 | 13,096 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $264,817 | 1,421 | Shares | Sole | 2021-07-15 | |
| 2020-12-31 | $1,229,168 | 7,427 | Shares | Sole | 2021-02-01 | |
| 2020-03-31 | $37,051,636 | 314,824 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||